Aberdeen Group
TNYA icon

Aberdeen Group’s Tenaya Therapeutics TNYA Stock Holding History

Aberdeen Group’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-600,700
Closed -$973K – 987
2025
Q3 		$973K Hold
600,700
– – ﹤0.01% 837
2025
Q2 		$367K Hold
600,700
– – ﹤0.01% 906
2025
Q1 		$342K Hold
600,700
– – ﹤0.01% 896
2024
Q4 		$859K Buy
600,700
+50,000
+9% +$112K ﹤0.01% 832
2024
Q3 		$1.06M Buy
+550,700
New +$1.55M ﹤0.01% 804

Other funds holding TNYA

CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Empery Asset Management New York $83M AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BGM
Burkehill Global Management New York $2.02B AUM 85.32% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $141M AUM

Aberdeen Group's TNYA Position: Q4 2025 in Review

Aberdeen Group sold out of Tenaya Therapeutics (TNYA) in Q4 2025, closing a stake of 600,700 shares — an estimated $973K sold.

Aberdeen Group first reported a position in TNYA in Q3 2024 and held it in 5 quarters. The position peaked at $1.06M in Q3 2024. 97 funds tracked by Wall St. Rank hold TNYA as of Q4 2025.

  • Aberdeen Group reported no remaining Tenaya Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Aberdeen Group sold 600,700 Tenaya Therapeutics shares in Q4 2025, an estimated $973K.
  • Aberdeen Group first reported a position in Tenaya Therapeutics in Q3 2024 and held it in 5 quarters.
  • Aberdeen Group's Tenaya Therapeutics position peaked at $1.06M in Q3 2024.
  • 97 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q4 2025.

Based on Aberdeen Group's 13F filing for Q4 2025, filed 16 Jan 2026.